394 related articles for article (PubMed ID: 11207513)
1. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
[TBL] [Abstract][Full Text] [Related]
2. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
[TBL] [Abstract][Full Text] [Related]
3. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.
Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW
Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943
[TBL] [Abstract][Full Text] [Related]
4. Ongoing gastric acid inhibition is a confounding factor in Helicobacter pylori diagnosis.
Jonkers D; Houben P; Stobberingh E; Stockbrügger R
Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):49-53. PubMed ID: 9031899
[TBL] [Abstract][Full Text] [Related]
5. Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection.
Martínek J; Blum AL; Stolte M; Hartmann M; Verdú EF; Lühmann R; Dorta G; Wiesel P
Aliment Pharmacol Ther; 1999 Jan; 13(1):27-34. PubMed ID: 9892876
[TBL] [Abstract][Full Text] [Related]
6. Effect of Helicobacter pylori infection on gastric juice pH.
Furuta T; Baba S; Takashima M; Futami H; Arai H; Kajimura M; Hanai H; Kaneko E
Scand J Gastroenterol; 1998 Apr; 33(4):357-63. PubMed ID: 9605256
[TBL] [Abstract][Full Text] [Related]
7. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
Uemura N; Okamoto S; Yamamoto S; Matsumura N; Yamaguchi S; Mashiba H; Sasaki N; Taniyama K
Aliment Pharmacol Ther; 2000 Oct; 14(10):1345-52. PubMed ID: 11012481
[TBL] [Abstract][Full Text] [Related]
8. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies.
Dickey W; Kenny BD; McConnell JB
Aliment Pharmacol Ther; 1996 Jun; 10(3):289-93. PubMed ID: 8791953
[TBL] [Abstract][Full Text] [Related]
9. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
[TBL] [Abstract][Full Text] [Related]
10. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
11. Is the sensitivity to gastric acid inhibition Helicobacter pylori status-dependent?
Smout AJ
Scand J Gastroenterol Suppl; 1998; 225():32-5. PubMed ID: 9515750
[TBL] [Abstract][Full Text] [Related]
12. Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole.
Vermeer IT; Engels LG; Pachen DM; Dallinga JW; Kleinjans JC; van Maanen JM
Gastroenterology; 2001 Sep; 121(3):517-25. PubMed ID: 11522734
[TBL] [Abstract][Full Text] [Related]
13. Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis.
Capurso G; Ricci R; Panzuto F; Baccini F; Passi S; Di Giulio E; Delle Fave G; Annibale B
Helicobacter; 2003 Aug; 8(4):300-6. PubMed ID: 12950602
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori.
Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():229-34. PubMed ID: 11966546
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.
Thomson AB; Keelan M; Lastiwka R; Appelman-Eszczuk S; Zuk L; Drozdowski L; Prentice A; Sinclair P
Dig Dis Sci; 2003 Oct; 48(10):2045-56. PubMed ID: 14627354
[TBL] [Abstract][Full Text] [Related]
17. Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD.
Mukaisho K; Hagiwara T; Nakayama T; Hattori T; Sugihara H
World J Gastroenterol; 2014 Sep; 20(34):11962-5. PubMed ID: 25232231
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
[TBL] [Abstract][Full Text] [Related]
19. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
20. The Reduction in Gastric Atrophy after
Niikura R; Hayakawa Y; Hirata Y; Ogura K; Fujishiro M; Yamada A; Ushiku T; Konishi M; Fukayama M; Koike K
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
